Little State, Big Dreams


As far as research institutes go, the Delaware Biotechnology Institute had an unusual birth. First established in 1999 and formalized with its own building in 2001, the institute was formed as part of a statewide economic development program. "The idea was really to support Delaware's economy by promoting life science type businesses and healthcare," says Kelvin Lee, who took over as director of the institute last fall. "Historically, Delaware has been a base initially for the chemical industry [and later] the credit card industry.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.